Last reviewed · How we verify
NCT05505253
Alfacalcidol Supplementation on Levator Ani Muscle Strength of Menopausal Pelvic Organ Prolapse Patients
Phase 3 trial testing Alfacalcidol 0.0005 MG in Pelvic Organ Prolapse in 48 participants. Completed in 31 December 2021.
31 October 2021
Quick facts
| Lead sponsor | Universitas Padjadjaran |
|---|---|
| Phase | Phase 3 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 48 |
| Start date | 1 November 2020 |
| Primary completion | 31 October 2021 |
| Estimated completion | 31 December 2021 |
| Sites | 1 location across Indonesia |
Drugs / interventions tested
- Alfacalcidol 0.0005 MG — full drug profile →
- Placebo
Conditions studied
- Pelvic Organ Prolapse — all drugs for Pelvic Organ Prolapse →
Sponsor
Universitas Padjadjaran — full company profile →
Who can join
Adults 40 to 75, female only, with Pelvic Organ Prolapse. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a study performed to evaluate the role of vitamin D supplementation on the strength of levator ani muscle in menopausal women with pelvic organ prolapse
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Nuclear receptors in health and disease: signaling pathways, biological functions and pharmaceutical interventions.
Jin P, Duan X, Huang Z, Dong Y, et al · · 2025 · cited 21× · PMID 40717128 · DOI 10.1038/s41392-025-02270-3
Verify or expand the search:
- PubMed search for NCT05505253
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pelvic Organ Prolapse
Currently open trials in the same condition.
- NCT07471464 — Centered Surgery - Preoperative Counseling and Patient Satisfaction · recruiting
- NCT07104292 — Pelvic Floor Muscle Training During Pregnancy · NA · recruiting
- NCT07218016 — The AccelERate Trial · NA · recruiting
- NCT07114029 — VNOTES Approach in Mesh Free Sacrocolpopexy: A Functional and Anatomic Evaluation · NA · recruiting
- NCT07082023 — Comparison of V-NOTES and Laparoscopic Mesh-Free Sacrocolpopexy Techniques · NA · recruiting
Other Universitas Padjadjaran trials
Trials by the same sponsor.
- NCT07506486 — Effect of Immersive Virtual Reality Cognitive Rehabilitation on Subacute Stroke Patients (A Pilot Study) · NA · not yet recruiting
- NCT07494357 — Effects of Dual Task-Oriented Circuit Training on Walking Recovery in Sub-acute Stroke · NA · not yet recruiting
- NCT07451899 — TB Type and Spirometry Result vs. Functional Capacity Based on 6MWT in People With Post-TB Lung Disease · not yet recruiting
- NCT07467954 — Comparative Effectiveness of Long-Pulsed 1064-nm Nd:YAG and Fractional CO₂ Laser in Skin Rejuvenation · NA · recruiting
- NCT07344688 — The Effect of White Tea in Healthy Human Subjects · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05505253 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universitas Padjadjaran
- Last refreshed: 17 August 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05505253.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing